<DOC>
	<DOCNO>NCT01512498</DOCNO>
	<brief_summary>The study evaluate prevalence characteristic vulvovaginal graft versus host disease ( VV- GVHD ) patient underwent hematopoietic stem cell transplantation ( HSCT ) girls adolescent compare prevalence , characteristic severity VV-GVHD menarche .</brief_summary>
	<brief_title>Vulvovaginal Graft Versus Host Disease ( VV-GVHD ) Women Who Underwent Transplantation Before After Menarche</brief_title>
	<detailed_description>The phenomenon vulvovaginal graft versus host disease ( VV-GVHD ) follow hematopoietic stem cell transplantation ( HSCT ) first described 1982 [ Corson ] . It characterize vulvovaginal inflammation , scar , adhesion might end complete vaginal obliteration . Hematopoietic stem cell source allogeneic transplantation find affect incidence VV-GVHD : peripheral blood progenitor cell associate incidence 50 % [ Zantomio ] , bone-marrow harvest cell associate incidence 25 % [ Spinelli ] . Due high incidence genital GVHD severe consequence establish clinic designate post- transplantation patient Hadassah University Hospital Jerusalem . In two year follow-up find incidence 54 % vulvovaginal GVHD adult patient attend clinic , similar incidence describe literature . The data VV-GVHD literature refers mainly adult woman . As gynecological examination follow-up do routinely girls adolescent sexually active , incidence characteristic VV-GVHD girl adolescent underwent HSCT unknown . Methods : Patients underwent allogeneic HSCT age 18 , 18 year old time study alive invite participate study . Those willing participate complete questionnaire undergo physical gynecological examination . At single appointment , data acquire regarding : age , time transplantation , current medical status , medication , hormonal status , marital status , sexual function fertility ( pregnancy delivery ) , assessment sexual development pediatric endocrinologist regard Tunner stage , data regard possible vulvovaginal involvement , presence score GVHD organ assessment patient ' well use FACT-BMT score . In order ass engraftment degree chimerism , donor host-specific DNA marker , use male female amelogenine gene PCR band STR-PCR assay do . Gynecological exam : case patient sexually active , complete vulvovaginal exam use speculum , bimanual exam transvaginal ultrasound do . In case patient never sexual intercourse , external ( vulvar ) exam abdominal ultrasound exam do . On exam , follow aspect evaluate : vulvar anatomy , vaginal examination adhesion , fibrosis stenosis . Vaginal exam include vaginal pH measurement , saline 10 % potassium hydroxide microscopy , evaluation presence condylomas , Pap smear vaginal cervical swab HPV . VV-GVHD define accord clinical criterion , include vulvovaginal anatomic change , mucosal erosion inflammation . Blood sample examine : hormonal status , measurement blood Th1/Th2 cytokine immunoglobulins level . Immune reconstitution evaluate quantitative immune reconstitution do use peripheral blood cell . The cell analyze flow cytometry use fluorescein isothiocyanate antibody absolute count various T cell sub population , B cell , NK NKT cell . Additional data regarding age transplantation , menarchal status transplantation , sexual activity status time transplantation , diagnosis , donor relation , source cell , number cell infuse , protocol , condition regimen , immunosuppressive prophylaxis occurrence GVHD organs acquire anamnesis patient ' file .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Inclusion criterion : Patients underwent allogeneic HSCT age 18 , 18 year old time study willing participate study . able comply study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>VV GVHD</keyword>
	<keyword>girl</keyword>
	<keyword>adolescent</keyword>
	<keyword>HSCT</keyword>
</DOC>